litlas
ログインアカウント作成

Boris Hadaschik

2008–2025 年に発表

171
論文数
20,424
被引用数
68
h 指数
151
i10 指数

被引用数

Boris Hadaschik の年別被引用数1961 年: 被引用 2 件1984 年: 被引用 3 件1998 年: 被引用 2 件2004 年: 被引用 1 件2009 年: 被引用 1 件2010 年: 被引用 12 件2011 年: 被引用 8 件2012 年: 被引用 21 件2013 年: 被引用 46 件2014 年: 被引用 92 件2015 年: 被引用 159 件2016 年: 被引用 258 件2017 年: 被引用 224 件2018 年: 被引用 308 件2019 年: 被引用 965 件2020 年: 被引用 900 件2021 年: 被引用 1,035 件2022 年: 被引用 737 件2023 年: 被引用 563 件2024 年: 被引用 1,072 件2025 年: 被引用 503 件2026 年: 被引用 22 件1962〜1983 年は被引用が無いため表示していません1985〜1997 年は被引用が無いため表示していません1999〜2003 年は被引用が無いため表示していません2005〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,677 件、この内訳の 19.2%ドイツ: 引用元論文 996 件、この内訳の 11.4%中国: 引用元論文 633 件、この内訳の 7.2%イタリア: 引用元論文 610 件、この内訳の 7%イギリス: 引用元論文 608 件、この内訳の 6.9%オランダ: 引用元論文 385 件、この内訳の 4.4%カナダ: 引用元論文 383 件、この内訳の 4.4%フランス: 引用元論文 324 件、この内訳の 3.7%スイス: 引用元論文 306 件、この内訳の 3.5%オーストラリア: 引用元論文 298 件、この内訳の 3.4%ベルギー: 引用元論文 218 件、この内訳の 2.5%日本: 引用元論文 183 件、この内訳の 2.1%
0%19.2%その他 24.3%

機関

分野

  • Medicine86.5%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology2.5%
  • Computer Science2.1%
  • Engineering1.5%
  • Materials Science0.7%
  • その他1.7%

トピック

  • Prostate Cancer Treatment and Research20.9%
  • Prostate Cancer Diagnosis and Treatment18.4%
  • Radiopharmaceutical Chemistry and Applications8.7%
  • Urologic and reproductive health conditions2.8%
  • MRI in cancer diagnosis2.5%
  • Radiomics and Machine Learning in Medical Imaging2.5%
  • その他44.2%

共著者

全論文

検索で開く
  1. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    著者: Veeru Kasivisvanathan, Antti Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A. Mynderse, Markku H. Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard Hindley, Monique J. Roobol, Scott E. Eggener, Maneesh Ghei, Arnauld Villers, Franck Bladou, Geert Villeirs, Jaspal Virdi, Silvan Boxler, G. Robert, Paras B. Singh, Wulphert Venderink, Boris Hadaschik, A. Ruffion, Jim C. Hu, Daniel Margolis, Sébastien Crouzet, Laurence Klotz, Samir S. Taneja, Peter A. Pinto, Inderbir S. Gill, Clare Allen, Francesco Giganti, Alex Freeman, Stephen Morris, Shonit Punwani, Norman Williams, Chris Brew‐Graves, Jonathan J Deeks, Yemisi Takwoingi, Mark Emberton, Caroline M. Moore - New England Journal of Medicine 2018 被引用: 3,016

  2. Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

    著者: Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Angela Lopez‐Gitlitz, Géralyn C. Trudel, Byron M. Espina, Youyi Shu, Youn C. Park, Wayne Rackoff, Margaret K. Yu, Eric J. Small - New England Journal of Medicine 2018 被引用: 1,326

  3. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)

    著者: Robert Seifert, Louise Emmett, Steven P. Rowe, Ken Herrmann, Boris Hadaschik, Jérémie Calais, Frederik L. Giesel, Robert E. Reiter, Tobias Maurer, Matthias Heck, Andrei Gafita, Michael J. Morris, Stefano Fanti, Wolfgang Weber, Thomas A. Hope, Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber - European Urology 2023 被引用: 276

  4. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

    著者: Matthias Eiber, Ken Herrmann, Jérémie Calais, Boris Hadaschik, Frederik L. Giesel, Markus Hartenbach, Thomas A. Hope, Robert E. Reiter, Tobias Maurer, Wolfgang Weber, Wolfgang P. Fendler - Journal of Nuclear Medicine 2017 被引用: 611

  5. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study

    著者: Andrei Gafita, Jérémie Calais, Tristan Grogan, Boris Hadaschik, Hui Wang, Manuel Weber, Shahneen Sandhu, Clemens Kratochwil, Rouzbeh Esfandiari, Robert Tauber, Anna Zeldin, Hendrik Rathke, Wesley R. Armstrong, Andrew Robertson, Pan Thin, Calogero D’Alessandria, Matthew B. Rettig, Ebrahim S. Delpassand, Uwe Haberkorn, David Elashoff, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber - The Lancet Oncology 2021 被引用: 246

  6. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients

    著者: Frederik L. Giesel, Boris Hadaschik, Jens Cardinale, Jan Philipp Radtke, Maria Vinsensia, Wencke Lehnert, Claudia Kesch, Yanis Tolstov, Samuel Singer, Niels Grabe, Stefan Duensing, Martin Schäfer, Oliver Neels, Walter Mier, Uwe Haberkorn, Klaus Kopka, Clemens Kratochwil - European Journal of Nuclear Medicine and Molecular Imaging 2016 被引用: 602

  7. Apalutamide and Overall Survival in Prostate Cancer

    著者: Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Peter De Porre, Alexis K. Smith, Sabine Brookman‐May, Susan Li, Ke Zhang, Brendan Rooney, Angela Lopez‐Gitlitz, Eric J. Small - European Urology 2020 被引用: 290

  8. Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches

    著者: Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik, Viktor Grünwald - Cancers 2023 被引用: 129

  9. Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer

    著者: Andrei Gafita, Loïc Djaileb, Isabel Rauscher, Wolfgang P. Fendler, Boris Hadaschik, Steven P. Rowe, Ken Herrmann, Jérémie Calais, Matthew B. Rettig, Matthias Eiber, Manuel Weber, Matthias Benz, Andrea Farolfi - Radiology 2023 被引用: 101

  10. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study

    著者: Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park, Jesús García-Donás, Robert Huddart, Earle F. Burgess, Mark T. Fleming, Arash Rezazadeh Kalebasty, Begoña Mellado, Sergei Varlamov, Monika Joshi, Ignacio Durán, Scott T. Tagawa, Yousef Zakharia, Sydney Akapame, Ademi Santiago-Walker, Manish Monga, Anne O’Hagan, Yohann Loriot, Andrea Necchi, Yohann Loriot, Se Hoon Park, Scott T. Tagawa, Aude Fléchon, B. Ya. Alexeev, Sergey Varlamov, Robert Huddart, Earle F. Burgess, Arash Rezazadeh, Arlene O. Siefker‐Radtke, Yann Vano, Donatello Gasparro, Alketa Hamzaj, Eugeniy Kopyltsov, Jesus Gracia Donas, Begoña Mellado, Omi Parikh, Peter Schatteman, Stéphane Culine, Nadine Houédé, Sylvie Zanetta, Gaetano Facchini, Giorgio V. Scagliotti, Giovanni Schinzari, Jae‐Lyun Lee, Mikhail Shkolnik, Mark T. Fleming, Monika Joshi, Peter H. O’Donnell, Herbert Stöger, Karel Decaestecker, Luc Dirix, Jean Pascal Machiels, Dephine Borchiellini, R. Delva, Frédéric Rolland, Boris Hadaschik, Margitta Retz, Eli Rosenbaum, Umberto Basso, Alessandra Mosca, Hyo Jin Lee, Dong Bok Shin, C. Cebotaru, Ignacio Durán, Víctor Moreno, José Luis Perez‐Gracia, Álvaro Pinto, Wen-Pin Su, Shian‐Shiang Wang, John D. Hainsworth, Ian D. Schnadig, Sandhya Srinivas, Nicholas J. Vogelzang, Wolfgang Loidl, Johannes Meran, M. Gross Goupil, Florence Joly, Florian Imkamp, Theodor Klotz, S. Krege, Matthias May, Wolfgang Schultze-Seemann, Arne Strauß, Uwe Zimmermann, Daniel Keizman, Avivit Peer, Avishai Sella, Rossana Berardi, Ugo De Giorgi, Cora N. Sternberg, Sun Young Rha, Iurie Bulat, А. А. Измайлов, Vsevolod Matveev, Vladimir Vladimirov, Joan Carles, Albert Font, M.I. Sáez, Isabel Syndikus ほか 6 名 - The Lancet Oncology 2022 被引用: 169

  11. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

    著者: Stefano Fanti, Karolien Goffin, Boris Hadaschik, Ken Herrmann, Tobias Maurer, Steven MacLennan, Daniela E. Oprea‐Lager, Wim J.G. Oyen, Olivier Rouvière, Nicolas Mottet, Anders Bjartell - European Journal of Nuclear Medicine and Molecular Imaging 2020 被引用: 205

  12. Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

    著者: Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Michael S. Hofman, Jérémie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J. Small, Matthew R. Smith, Paola M. Perez, Thomas A. Hope, Isabel Rauscher, Anil Londhe, Angela Lopez‐Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Boris Hadaschik - Clinical Cancer Research 2019 被引用: 267

  13. PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

    著者: Robert Seifert, Katharina Kessel, Katrin Schlack, Manuel Weber, Ken Herrmann, Maximilian Spanke, Wolfgang P. Fendler, Boris Hadaschik, Jens Kleesiek, Michael Schäfers, Matthias Weckesser, Martin Boegemann, Kambiz Rahbar - European Journal of Nuclear Medicine and Molecular Imaging 2020 被引用: 152

  14. Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria

    著者: Stefano Fanti, Boris Hadaschik, Ken Herrmann - Journal of Nuclear Medicine 2019 被引用: 157

  15. Next generation radiotheranostics promoting precision medicine

    著者: Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, Silke Gillessen, Christopher J. Sweeney, Tim Maughan, Michael S. Hofman, Ken Herrmann - Annals of Oncology 2023 被引用: 69

  16. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

    著者: Ali Afshar‐Oromieh, A. Malcher, Matthias Eder, Michael Eisenhut, Heinz Linhart, Boris Hadaschik, Tim Holland‐Letz, Frederik L. Giesel, Clemens Kratochwil, Sabine Haufe, Uwe Haberkorn, Christian M. Zechmann - European Journal of Nuclear Medicine and Molecular Imaging 2012 被引用: 924

  17. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets

    著者: Stephan Lang, Kirsten Bruderek, Cordelia Kaspar, Benedikt Höing, Oliver Kanaan, Nina Dominas, Timon Hussain, Freya Droege, Christian Eyth, Boris Hadaschik, Sven Brandau - Clinical Cancer Research 2018 被引用: 211

  18. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities

    著者: Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans‐Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Céline Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann, Wolfgang P. Fendler - Journal of Nuclear Medicine 2022 被引用: 70

  19. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

    著者: Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel, Tim Holland‐Letz, Heinz Linhart, Matthias Eder, Michael Eisenhut, Silvan Boxler, Boris Hadaschik, Clemens Kratochwil, Wilko Weichert, Klaus Kopka, Jürgen Debus, Uwe Haberkorn - European Journal of Nuclear Medicine and Molecular Imaging 2014 被引用: 974

  20. Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort

    著者: Stefanie Zschäbitz, Nadine Biernath, Thomas Hilser, Alexander Höllein, Friedemann Zengerling, Jozefina Cascucelli, Pia Paffenholz, Daniel Seidl, Christoph Lutz, Katrin Schlack, D. Kingreen, Niklas Klümper, Philipp Ivanyi, Gunhild von Amsberg, Hendrik Heers, Florian Roghmann, Robert L. Tauber, Richard Cathomas, Luisa Hofer, Günter Niegisch, M. Klee, Roland Ehrenberg, Andreas Hassler, Boris Hadaschik, Viktor Grünwald, Christopher Darr - European Urology Open Science 2023 被引用: 45

  21. The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction

    著者: Florian Distler, Jan Philipp Radtke, David Bonekamp, Claudia Kesch, Heinz-Peter Schlemmer, Kathrin Wieczorek, Marietta Kirchner, Sascha Pahernik, Markus Hohenfellner, Boris Hadaschik - The Journal of Urology 2017 被引用: 245

  22. Unspecific18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer

    著者: Robert Seifert, Tuğçe Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann, Wolfgang P. Fendler - Journal of Nuclear Medicine 2022 被引用: 70

  23. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

    著者: Ali Afshar‐Oromieh, Christian M. Zechmann, A. Malcher, Matthias Eder, Michael Eisenhut, Heinz Linhart, Tim Holland‐Letz, Boris Hadaschik, Frederik L. Giesel, Jürgen Debus, Uwe Haberkorn - European Journal of Nuclear Medicine and Molecular Imaging 2013 被引用: 928

  24. Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

    著者: Richard Cathomas, Sacha I. Rothschild, Stefanie Hayoz, Lukas Bubendorf, Berna C. Özdemir, Bernhard Kiss, Andreas Erdmann, Stefanie Aeppli, Nicolas Mach, Räto T. Strebel, Boris Hadaschik, Dominik Berthold, Hubert John, Deborah Zihler, Mathias Schmid, Ilaria Alborelli, Martina Schneider, Jana Musilová, Martin Spahn, Ulf Petrausch - Journal of Clinical Oncology 2023 被引用: 42